HSBC Holdings’s Boston Scientific BSX Stock Holding History

HSBC Holdings’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,400	Closed	-$3.29M	–	2926
2025 Q4	$3.29M	Hold	34,400	–	–	﹤0.01%	1376
2025 Q3	$3.36M	Hold	34,400	–	–	﹤0.01%	1331
2025 Q2	$3.68M	Buy	34,400 +1,700	+5%	+$172K	﹤0.01%	1263
2025 Q1	$3.27M	Sell	32,700 -31,900	-49%	-$3.21M	﹤0.01%	1262
2024 Q4	$5.79M	Buy	64,600 +19,200	+42%	+$1.69M	﹤0.01%	1091
2024 Q3	$3.77M	Buy	+45,400	New	+$3.58M	﹤0.01%	1207
2024 Q2	–	Sell	-32,400	Closed	-$2.22M	–	2957
2024 Q1	$2.22M	Buy	32,400 +14,400	+80%	+$926K	﹤0.01%	1433
2023 Q4	$1.04M	Hold	18,000	–	–	﹤0.01%	1746
2023 Q3	$954K	Hold	18,000	–	–	﹤0.01%	1742
2023 Q2	$974K	Buy	+18,000	New	+$940K	﹤0.01%	1728
2023 Q1	–	Sell	-54,400	Closed	-$2.5M	–	2704
2022 Q4	$2.5M	Hold	54,400	–	–	﹤0.01%	1585
2022 Q3	$2.14M	Buy	54,400 +36,500	+204%	+$1.46M	﹤0.01%	1537
2022 Q2	$672K	Buy	17,900 +16,100	+894%	+$655K	﹤0.01%	2150
2022 Q1	$81K	Sell	1,800 -103,200	-98%	-$4.47M	﹤0.01%	3154
2021 Q4	$4.5M	Buy	105,000 +23,700	+29%	+$996K	﹤0.01%	1312
2021 Q3	$3.56M	Buy	81,300 +44,600	+122%	+$1.97M	﹤0.01%	1299
2021 Q2	$1.56M	Sell	36,700 -8,400	-19%	-$353K	﹤0.01%	1539
2021 Q1	$1.75M	Sell	45,100 -42,100	-48%	-$1.59M	﹤0.01%	1356
2020 Q4	$3.1M	Buy	87,200 +64,100	+277%	+$2.31M	﹤0.01%	1199
2020 Q3	$887K	Buy	+23,100	New	+$890K	﹤0.01%	1602
2020 Q2	–	Sell	-86,100	Closed	-$2.83M	–	2666
2020 Q1	$2.83M	Sell	86,100 -43,800	-34%	-$1.71M	0.01%	1045
2019 Q4	$5.85M	Hold	129,900	–	–	0.01%	1042
2019 Q3	$5.29M	Buy	129,900 +87,600	+207%	+$3.71M	0.01%	1160
2019 Q2	$1.82M	Buy	42,300 +5,800	+16%	+$223K	﹤0.01%	1555
2019 Q1	$1.4M	Buy	36,500 +18,600	+104%	+$710K	﹤0.01%	1658
2018 Q4	$633K	Hold	17,900	–	–	﹤0.01%	2006
2018 Q3	$689K	Hold	17,900	–	–	﹤0.01%	1894
2018 Q2	$585K	Hold	17,900	–	–	﹤0.01%	2008
2018 Q1	$489K	Buy	+17,900	New	+$486K	﹤0.01%	1936
2017 Q4	–	Sell	-14,000	Closed	-$408K	–	2072
2017 Q3	$408K	Buy	+14,000	New	+$387K	﹤0.01%	1804
2017 Q2	–	Sell	-50,000	Closed	-$1.24M	–	2190
2017 Q1	$1.24M	Buy	+50,000	New	+$1.22M	﹤0.01%	1358
2016 Q4	–	Sell	-230,000	Closed	-$5.47M	–	2725
2016 Q3	$5.47M	Buy	230,000 +30,000	+15%	+$716K	0.01%	881
2016 Q2	$4.67M	Buy	+200,000	New	+$4.33M	0.01%	933

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings's BSX Position: Q1 2026 in Review

HSBC Holdings reduced its Boston Scientific (BSX) stake by 5.9% in Q1 2026, selling an estimated $17M and leaving 3,399,703 shares worth $213M. The position accounts for 0.11% of the portfolio, ranked #182.

HSBC Holdings first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $345M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

HSBC Holdings held 3,399,703 shares of Boston Scientific worth $213M as of Q1 2026.
HSBC Holdings sold 212,549 Boston Scientific shares in Q1 2026, an estimated $17M.
Boston Scientific made up 0.11% of HSBC Holdings's portfolio in Q1 2026, its #182 holding.
HSBC Holdings first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's Boston Scientific position peaked at $345M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.